Nuveen Asset Management
ALXN

Nuveen Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-715,115
Closed -$131M 3360
2021
Q2
$131M Sell
715,115
-37,508
-5% -$6.89M 0.04% 395
2021
Q1
$115M Sell
752,623
-36,763
-5% -$5.62M 0.04% 418
2020
Q4
$123M Sell
789,386
-224,620
-22% -$35.1M 0.04% 382
2020
Q3
$116M Sell
1,014,006
-184,872
-15% -$21.2M 0.04% 335
2020
Q2
$135M Sell
1,198,878
-288,885
-19% -$32.4M 0.05% 290
2020
Q1
$134M Sell
1,487,763
-28,386
-2% -$2.55M 0.07% 256
2019
Q4
$164M Buy
1,516,149
+295,356
+24% +$31.9M 0.06% 292
2019
Q3
$120M Sell
1,220,793
-2,416,351
-66% -$237M 0.05% 360
2019
Q2
$476M Buy
3,637,144
+3,630,846
+57,651% +$476M 0.19% 104
2019
Q1
$851K Buy
6,298
+117
+2% +$15.8K ﹤0.01% 767
2018
Q4
$602K Buy
6,181
+110
+2% +$10.7K ﹤0.01% 792
2018
Q3
$844K Sell
6,071
-176
-3% -$24.5K ﹤0.01% 772
2018
Q2
$776K Sell
6,247
-236
-4% -$29.3K ﹤0.01% 784
2018
Q1
$723K Sell
6,483
-159,559
-96% -$17.8M ﹤0.01% 819
2017
Q4
$19.9M Buy
166,042
+77,619
+88% +$9.28M 0.13% 243
2017
Q3
$12.4M Sell
88,423
-11,321
-11% -$1.59M 0.08% 353
2017
Q2
$12.1M Buy
99,744
+1,132
+1% +$138K 0.08% 361
2017
Q1
$12M Buy
98,612
+19,775
+25% +$2.4M 0.07% 381
2016
Q4
$9.65M Sell
78,837
-22,686
-22% -$2.78M 0.05% 469
2016
Q3
$12.4M Sell
101,523
-805
-0.8% -$98.6K 0.07% 329
2016
Q2
$11.9M Buy
102,328
+79,074
+340% +$9.23M 0.07% 322
2016
Q1
$3.24K Sell
23,254
-40,482
-64% -$5.64K 0.02% 595
2015
Q4
$12.2K Buy
63,736
+4,552
+8% +$868 0.06% 299
2015
Q3
$9.26K Sell
59,184
-400
-0.7% -$63 0.05% 346
2015
Q2
$10.8K Sell
59,584
-70,133
-54% -$12.7K 0.06% 364
2015
Q1
$22.5M Sell
129,717
-1,286
-1% -$223K 0.12% 235
2014
Q4
$24.2M Sell
131,003
-10,860
-8% -$2.01M 0.14% 205
2014
Q3
$23.5M Buy
141,863
+2,513
+2% +$417K 0.14% 187
2014
Q2
$21.8M Sell
139,350
-60,890
-30% -$9.51M 0.13% 208
2014
Q1
$30.5M Buy
200,240
+1,003
+0.5% +$153K 0.18% 126
2013
Q4
$26.5M Buy
199,237
+56,554
+40% +$7.52M 0.17% 167
2013
Q3
$16.6M Buy
142,683
+127,351
+831% +$14.8M 0.11% 248
2013
Q2
$1.41M Buy
+15,332
New +$1.41M 0.01% 835